Events & Presentations
Sub Nav Events & Presentations
Events & Presentations
Events & Presentations
Upcoming Events
Events & Presentations
Past Events
Nov 19 - Nov 21, 2024
Barinthus Bio’s management will be available for one-to-one meetings.
Nov 15 - Nov 19, 2024
Supporting Materials
Nov 11 - Nov 13, 2024
Fireside Chat webcast timing: 14:00-14:30 AM ET, Monday, November 11.
Barinthus Bio's management will also be available for one-to-one meetings.
Sep 9 - Sep 11, 2024
Webcast timing: 09:00-09:30 AM ET, Monday, September 9
Jun 5 - Jun 8, 2024
Supporting Materials
Nov 14 - Nov 16, 2023
Nov 10 - Nov 14, 2023
Supporting Materials
Oct 25, 2023
Our presentation will be webcast live from 10:30-11:00 am ET.
Sep 20, 2023 from 2:00 PM to 3:00 PM EDT
Sep 11 - Sep 13, 2023
Sep 11 - Sep 13, 2023
The presentation will be webcast live on Monday 11 September from 9:30-10:00 AM ET.
Jun 21 - Jun 24, 2023
Supporting Materials
Jun 2 - Jun 6, 2023
Supporting Materials
May 23 - May 24, 2023
Apr 17 - Apr 21, 2023
Supporting Materials
Mar 13 - Mar 15, 2023
Jan 9 - Jan 12, 2023
Nov 29 - Dec 1, 2022
Nov 28, 2022 4:30 PM EST to Nov 28, 2022 5:30 PM EST
Featuring Robert Anderson, MD, PhD (Novoviah Pharmaceuticals, Brisbane, Australia) and Professor Christopher Jewell, PhD (University of Maryland) discussing the unmet needs and current status of treatments for celiac disease and other autoimmunity indications, along with the potential for tolerogenic immunotherapies in the current treatment landscape. The event also highlighted Vaccitech’s SNAPvax™ platform and other nanoparticle technologies for enabling immunotherapies to induce tolerance, with a review of the latest supporting data.
Jun 22 - Jun 26, 2022
Supporting Materials
Poster 3328 EASL 2022 1.8 MB
Jan 25, 2022 from 8:30 AM to 10:00 AM EST
Supporting Materials
Vaccitech HBV KOL Presentation 11.4 MB
Dec 14, 2021 from 8:30 AM to 9:30 AM EST
Supporting Materials
Nov 12 - Nov 15, 2021
The Liver Meeting will be held virtually on November 12-15, 2021. The meeting platform and posters will be available to attendees on 8th November 8.00am ET
Supporting Materials
View Press Release 111.5 KB
AASLD Abstract - 833 - HBV001 317.8 KB
AASLD 2021 HBV001 698.2 KB
AASLD 2021 HBV002 391.9 KB
Oct 21, 2021 7:30 AM EDT
Supporting Materials
Corporate Presentation 2.5 MB